Literature DB >> 11724751

In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA.

D M Cannon1, A K Keenan, P J Guiry, C Buon, A W Baird, G J McBean.   

Abstract

1. This study examined the effects of chronic exposure of rats to 3,4-methylenedioxymethamphetamine (MDMA) on [(3)H]5-hydroxytryptamine ([(3)H]5-HT) re-uptake into purified rat brain synaptosomes, 5-HT-induced isometric contraction of aortic rings and [(3)H]5-HT re-uptake into rat aorta. 2. Rats were administered MDMA (20 mg kg(-1) i.p.) twice daily over 4 days. One, 7, 14 or 21 days post treatment, whole brain synaptosomes and descending thoracic aortic rings were prepared for investigation. 3. Chronic MDMA treatment significantly reduced the maximum rate (V(max)) of specific high-affinity [(3)H]5-HT re-uptake 1 day after treatment and for up to 21 days post-final administration of MDMA. Direct application of MDMA (100 microM) abolished synaptosomal re-uptake of [(3)H]5-HT in vitro. 4. Chronic MDMA administration significantly reduced the maximum contraction (E(max)) to 5-HT at 1 and 7 days after treatment, but not at 14 or 21 days. 5. Chronic MDMA administration had no effect on sodium-dependent [(3)H]5-HT re-uptake into aorta 1 day after treatment, nor did 100 microM MDMA have any direct effect on [(3)H]5-HT uptake into aortic rings in vitro. 6. These results show, for the first time, an altered responsiveness of vascular tissue to MDMA after chronic administration. In addition, they demonstrate a difference in the sensitivity of central and peripheral 5-HT uptake systems to chronic MDMA exposure, and suggest that the action of MDMA in the cardiovascular system does not arise from a direct effect of MDMA on peripheral 5-HT transport.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724751      PMCID: PMC1573088          DOI: 10.1038/sj.bjp.0704402

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Investigation of the prejunctional alpha2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens.

Authors:  A Lavelle; V Honner; J R Docherty
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.

Authors:  B Esteban; E O'Shea; J Camarero; V Sanchez; A R Green; M I Colado
Journal:  Psychopharmacology (Berl)       Date:  2001-03       Impact factor: 4.530

3.  Pathology of deaths associated with "ecstasy" and "eve" misuse.

Authors:  C M Milroy; J C Clark; A R Forrest
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

4.  Mechanisms of extraneuronal serotonin uptake in the rat aorta.

Authors:  S Fukuda; C Su; T J Lee
Journal:  J Pharmacol Exp Ther       Date:  1986-10       Impact factor: 4.030

5.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

6.  Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.

Authors:  J McDaid; J R Docherty
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

7.  Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.

Authors:  E D O'Loinsigh; G Boland; J P Kelly; K M O'Boyle
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-04       Impact factor: 5.067

8.  Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase.

Authors:  F Bai; D C Jones; S S Lau; T J Monks
Journal:  Chem Res Toxicol       Date:  2001-07       Impact factor: 3.739

9.  Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.

Authors:  D E Nichols; D H Lloyd; A J Hoffman; M B Nichols; G K Yim
Journal:  J Med Chem       Date:  1982-05       Impact factor: 7.446

10.  Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine).

Authors:  U Braun; A T Shulgin; G Braun
Journal:  J Pharm Sci       Date:  1980-02       Impact factor: 3.534

View more
  2 in total

Review 1.  Differential effects of psychoactive drugs in adolescents and adults.

Authors:  Sari Izenwasser
Journal:  Crit Rev Neurobiol       Date:  2005

2.  Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users.

Authors:  Ralph Buchert; Rainer Thomasius; Kay Petersen; Florian Wilke; Jost Obrocki; Bruno Nebeling; Lutz Wartberg; Pavlina Zapletalova; Malte Clausen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-17       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.